TME Pharma announces the initiation of the listing of preferential subscription rights for fully guaranteed €2.7 million capital increase
This information is not intended for residents of the United Kingdom, United States, Australia, Canada or Japan. See Annex for full disclaimer. Guaranteed portion of the transaction will extend cash runway past regulatory milestones in Q1-2024 The financial visibility will Mehr






